Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB Volumes for Post-Mastectomy Pain
NCT05232084Completed
- Sponsor
- Istanbul Medipol University
- Start
- Jan 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Postoperative Opioid Consumption at 24 hours. Started Jan 2022; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05232084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05232084.